{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T11:41:16Z","timestamp":1777290076261,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ghir.2024.101626","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:21:43Z","timestamp":1728606103000},"page":"101626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The association between change in temporal muscle mass and treatment of acromegaly"],"prefix":"10.1016","volume":"79","author":[{"given":"Serdar","family":"Sahin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Saglamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Sulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Numan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lala","family":"Soltanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Duru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Kizilkilic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necmettin","family":"Tanriover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ghir.2024.101626_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.ghir.2024.101626_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000497214","article-title":"Growth hormone response to oral glucose load: from normal to pathological conditions","volume":"108","author":"Hage","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"11","key":"10.1016\/j.ghir.2024.101626_bb0015","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Endocrine Society, acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2024.101626_bb0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jocn.2010.10.003","article-title":"Treatment of persistent and recurrent acromegaly","volume":"18","author":"Del Porto","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ghir.2024.101626_bb0025","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"1;40(1)","author":"Gadelha","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2024.101626_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/0-387-26274-1_5","article-title":"Skeletal muscle","volume":"567","author":"Fernandez","year":"2005","journal-title":"Adv. Exp. Med. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2024.101626_bb0035","first-page":"26","article-title":"Effects of growth hormone and insulin-like growth factor I on muscle in mouse models of human growth disorders","volume":"66","author":"Clark","year":"2006","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2024.101626_bb0040","first-page":"1221 1225","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2024.101626_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.1994.tb02552.x","article-title":"Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study","volume":"41","author":"Hansen","year":"1994","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2024.101626_bb0050","first-page":"279","article-title":"Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency","volume":"84","author":"Janssen","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2024.101626_bb0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1530\/eje.0.1300224","article-title":"Three years of growth hormone treatment in growth hormone-deficient adults: near normalization of body composition and physical performance","volume":"130","author":"J\u00f8rgensen","year":"1994","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2024.101626_bb0060","first-page":"4570","article-title":"Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults","volume":"84","author":"Woodhouse","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.ghir.2024.101626_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207849","article-title":"High correlation of temporal muscle thickness with lumbar skeletal muscle crosssectional area in patients with brain metastases","volume":"13","author":"Leitner","year":"2018","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.ghir.2024.101626_bb0070","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.3390\/jcm9051272","article-title":"Sarcopenia in neurological patients: standard values for temporal muscle thickness and muscle strength evaluation","volume":"9","author":"Steindl","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ghir.2024.101626_bb0075","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12877-021-02086-0","article-title":"A change in temporal muscle thickness is correlated with past energy adequacy in bedridden older adults: a prospective cohort study","volume":"21","author":"Hasegawa","year":"2021","journal-title":"BMC Geriatr."},{"issue":"11","key":"10.1016\/j.ghir.2024.101626_bb0080","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s40618-023-02195-0","article-title":"The relationship between temporal muscle thickness and disease activity in Cushing\u2019s disease","volume":"46","author":"Ozaydin","year":"2023","journal-title":"J. Endocrinol. Invest."},{"issue":"14","key":"10.1016\/j.ghir.2024.101626_bb0085","doi-asserted-by":"crossref","first-page":"1256975","DOI":"10.3389\/fendo.2023.1256975","article-title":"Discordant biochemical parameters of acromegaly remission do not influence the prevalence or aggressiveness of metabolic comorbidities: a single-center study","volume":"27","author":"Romanisio","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"2","key":"10.1016\/j.ghir.2024.101626_bb0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11102-017-0858-y","article-title":"Silent somatotroph pituitary adenomas: an update","volume":"21","author":"Langlois","year":"2018","journal-title":"Pituitary"},{"issue":"11","key":"10.1016\/j.ghir.2024.101626_bb0095","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Supplement_1","key":"10.1016\/j.ghir.2024.101626_bb0100","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.ghir.2024.101626_bb0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"2018","key":"10.1016\/j.ghir.2024.101626_bb0110","first-page":"13","volume":"71","author":"Whelton","year":"2017","journal-title":"Hypertension"},{"issue":"36","key":"10.1016\/j.ghir.2024.101626_bb0115","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC Scientific Document Group. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"21;42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.ghir.2024.101626_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2362.1993.tb00762.x","article-title":"Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy","volume":"23","author":"Brummer","year":"1993","journal-title":"Eur. J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ghir.2024.101626_bb0125","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1210\/jc.2009-0026","article-title":"Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon X-ray absorptiometry","volume":"94","author":"Freda","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2024.101626_bb0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jcem.87.2.8206","article-title":"GH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly men","volume":"87","author":"Lange","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2024.101626_bb0135","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11102-020-01037-z","article-title":"The evaluation of the tendon and muscle changes of lower extremity in patients with acromegaly","volume":"23","author":"Ozturk","year":"2020","journal-title":"Pituitary"},{"issue":"8","key":"10.1016\/j.ghir.2024.101626_bb0140","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1007\/s00330-016-4707-6","article-title":"Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases","volume":"27","author":"Furtner","year":"2017","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.ghir.2024.101626_bb0145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-018-2948-8","article-title":"Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases","volume":"140","author":"Furtner","year":"2018","journal-title":"J. Neurooncol"},{"issue":"1","key":"10.1016\/j.ghir.2024.101626_bb0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1158\/1078-0432.CCR-21-1987","article-title":"Temporal muscle thickness as a prognostic marker in patients with newly diagnosed glioblastoma: translational imaging analysis of the CENTRIC EORTC 26071-22072 and CORE trials","volume":"28","author":"Furtner","year":"2022","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res."},{"issue":"12","key":"10.1016\/j.ghir.2024.101626_bb0155","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/neuonc\/noz131","article-title":"Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial","volume":"21","author":"Furtner","year":"2019","journal-title":"Neuro-Oncol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663742400056X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663742400056X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T07:55:35Z","timestamp":1731657335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109663742400056X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"alternative-id":["S109663742400056X"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2024.101626","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between change in temporal muscle mass and treatment of acromegaly","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2024.101626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101626"}}